Reconstructive neurosurgery for Parkinson's disease: a systematic review and preliminary meta-analysis.

No abstract is available for this paper.

• Publication year

  2003

• Venue

  Brain Research Bulletin

• Publication date

  2003-04-15

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/S0361-9230(03)00017-0PMID 12725889
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Economic and Health-Related Quality of Life Considerations of New Therapies in Parkinson’s Disease

  2012cited by this paper
• Transplantation of embryonic dopamine neurons for severe Parkinson's disease.

  2001cited by this paper
• Deep brain stimulation in the treatment of Parkinson’s disease

  2001cited by this paper
• Doubts over cell therapy for Parkinson's disease

  2001cited by this paper
• Placebo surgery in trials of therapy for Parkinson's disease.

  2000cited by this paper
• Impact of Parkinson's disease and its pharmacologic treatment on quality of life and economic outcomes.

  2000cited by this paper
• Placebo surgery in trials of therapy for Parkinson's disease.

  2000cited by this paper
• Placebo surgery in trials of therapy for Parkinson's disease.

  2000cited by this paper
• How does Parkinson's disease affect quality of life? A comparison with quality of life in the general population

  2000cited by this paper
• Outcomes and Complications of Fetal Tissue Transplantation in Parkinson’s Disease

  2000cited by this paper
• Long-term treatment with dopamine agonists in idiopathic in Parkinson's disease

  2000cited by this paper
• Bilateral caudate and putamen grafts of embryonic mesencephalic tissue treated with lazaroids in Parkinson's disease.

  2000cited by this paper
• Precursor cells for transplantation.

  2000cited by this paper
• Surgery for Parkinson disease: A critical evaluation of the state of the art.

  2000cited by this paper
• Movement disorders in people with Parkinson disease: a model for physical therapy.

  2000cited by this paper
• Placebo surgery in trials of therapy for Parkinson's disease.

  2000cited by this paper
• Transplantation of embryonic porcine mesencephalic tissue in patients with PD

  2000cited by this paper
• Transplantation therapy for Parkinson’s disease

  2000cited by this paper
• What contributes to quality of life in patients with Parkinson's disease?

  2000cited by this paper
• Core assessment program for surgical interventional therapies in Parkinson's disease (CAPSIT‐PD)

  1999cited by this paper
• Sequential bilateral transplantation in Parkinson's disease: effects of the second graft.

  1999cited by this paper
• Activation of neurotransplants in humans.

  1999cited by this paper
• Long-term evaluation of bilateral fetal nigral transplantation in Parkinson disease.

  1999cited by this paper
• Cerebral implantation in movement disorders: State of the art

  1999cited by this paper
• Neural transplantation for neurodegenerative disorders.

  1999cited by this paper
• Development of fetal neural transplantation as a treatment for Parkinson's disease.

  1999cited by this paper
• Use of placebo surgery in controlled trials of a cellular-based therapy for Parkinson's disease.

  1999cited by this paper
• FETAL TISSUE TRANSPLANATION IN PARKINSON'S DISEASE

  1998cited by this paper
• Fetal tissue transplantation [correction of transplanation] in Parkinson's disease.

  1998cited by this paper
• Sertoli cell transplants: their use in the treatment of neurodegenerative disease.

  1998cited by this paper
• Long-term improvement in patients with severe Parkinson's disease after implantation of fetal ventral mesencephalic tissue in a cavity of the caudate nucleus: 5-year follow up in 10 patients. Clinica Puerta de Hierro Neural Transplantation Group.

  1997cited by this paper
• Dopaminergic transplants in patients with Parkinson's disease: neuroanatomical correlates of clinical recovery.

  1997cited by this paper
• Outcome following intrastriatal fetal mesencephalic grafts for Parkinson's patients is directly related to the volume of grafted tissue.

  1997cited by this paper
• Short‐ and long‐term survival and function of unilateral intrastriatal dopaminergic grafts in Parkinson's disease

  1997cited by this paper
• From transplants to gene therapy for Parkinson's disease.

  1997cited by this paper
• Functional fetal nigral grafts in a patient with Parkinson's disease: Chemoanatomic, ultrastructural, and metabolic studies

  1996cited by this paper
• Clinical Study of Fetal Mesencephalic Intracerebral Transplants for the Treatment of Parkinson's Disease

  1996cited by this paper
• Long-term outcome of unilaterally transplanted parkinsonian patients. I. Clinical approach.

  1996cited by this paper
• The core assessment program for intracerebral transplantation.

  1995cited by this paper
• Transplantation of fetal mesencephalic tissue in Parkinson's disease.

  1995cited by this paper
• Clinical correlates of {18F}fluorodopa uptake in five grafted Parkinsonian patients

  1995cited by this paper
• Bilateral fetal nigral transplantation into the postcommissural putamen in Parkinson's disease

  1995cited by this paper
• A long term follow-up of fetal dopaminergic neurons transplantation into the brain of three parkinsonian patients

  1994cited by this paper
• Transplantation of fetal mesencephalic tissue in Parkinson's patients.

  1994cited by this paper
• Bilateral motor improvement and alteration of L-dopa effect in two patients with Parkinson's disease following intrastriatal transplantation of foetal ventral mesencephalon.

  1994cited by this paper
• Evidence for long‐term survival and function of dopaminergic grafts in progressive Parkinson's disease

  1994cited by this paper
• Meta-analysis of the literature or of individual patient data: is there a difference?

  1993cited by this paper
• Fetal tissue transplantation in Parkinson's disease.

  1993cited by this paper
• Bilateral fetal mesencephalic grafting in two patients with parkinsonism induced by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)

  1992cited by this paper
• Core assessment program for intracerebral transplantations (CAPIT)

  1992cited by this paper
• Unilateral transplantation of human fetal mesencephalic tissue into the caudate nucleus of patients with Parkinson's disease.

  1992cited by this paper
• Fetal-tissue transplants in Parkinson's disease.

  1992cited by this paper
• Peer Review for Fetal Tissue Transplantation Research

  1992cited by this paper
• Survival of implanted fetal dopamine cells and neurologic improvement 12 to 46 months after transplantation for Parkinson's disease.

  1992cited by this paper
• Implantation of human fetal ventral mesencephalon to the right caudate nucleus in advanced Parkinson's disease.

  1991cited by this paper
• Development of dopaminergic neurons in the human substantia nigra.

  1991cited by this paper
• Transplantation of embryonic dopamine neurons: what we know from rats

  1991cited by this paper
• Transplantation of human fetal dopamine cells for Parkinson's disease. Results at 1 year.

  1990cited by this paper
• Human fetal dopamine neurons grafted into the striatum in two patients with severe Parkinson's disease. A detailed account of methodology and a 6-month follow-up.

  1989cited by this paper
• Members of the UPDRS Development Committee. Unified Parkinson's Disease Rating Scale

  1987cited by this paper
• Reconstruction of the nigrostriatal dopamine pathway by intracerebral nigral transplants.

  1979cited by this paper
• Projection technique for evaluating surgery in Parkinson’s disease

  1969cited by this paper
• The Structure of Scientific Revolutions

  1963cited by this paper
• Parkinson's disease

  1940cited by this paper

• Overcoming Methodological Challenges for Advancing Stem Cell Therapies in Parkinson’s Disease

  2024cites this paper
• Cell-therapy for Parkinson’s disease: a systematic review and meta-analysis

  2023cites this paper
• The Placebo Response in Double-Blind Randomised Trials Evaluating Regenerative Therapies for Parkinson’s Disease: A Systematic Review and Meta-Analysis

  2022cites this paper
• Regenerative medicine for neurological diseases—will regenerative neurosurgery deliver?

  2021cites this paper
• Modelling alpha-synuclein-based Parkinson's disease and studies with CDNF

  2019cites this paper
• Evidence-Based Evaluation of the Ethics of Sham Surgery for Parkinson’s Disease

  2019cites this paper
• Is treatment with stem cells effective in Parkinson's disease?

  2018cites this paper
• Cell therapy for neurological disorders.

  2016cites this paper
• A Critical Evaluation of the Methodological Obstacles to Translating Cell-Based Research Into an Effective Treatment for People With Parkinson’s Disease

  2016cites this paper
• From mice to mind: Strategies and progress in translating neuroregeneration.

  2015cites this paper
• Development of a Stereotaxic Device for Low Impact Implantation of Neural Constructs or Pieces of Neural Tissues into the Mammalian Brain

  2014cites this paper
• Neurological Diseases and Stem Cell Therapy

  2013cites this paper
• Composite Brains: Toward a Systems Theory of Neural Reconstruction

  2013cites this paper
• Neural tissue transplantation, repair, and rehabilitation.

  2013cites this paper
• Stem Cell Therapy for Parkinson’s disease: Are Double-Blind Randomized Control Trials the Best Design for Quantifying Therapy Outcomes?

  2013cites this paper
• Cell-based therapies for Parkinson’s disease

  2011cites this paper
• Stem Cells for Central Nervous System Repair and Rehabilitation

  2011cites this paper
• Stem cell therapy for neurological disorders

  2011cites this paper
• Intracranial Delivery of Stem Cells

  2011cites this paper
• Stemming out of a new PML era?

  2009cites this paper
• [Biotherapies and Parkinson's disease].

  2009cites this paper
• The effect of functional electrical stimulation on akinetic gait in patients with Parkinson's disease

  2008cites this paper
• Stem cells and neurodegenerative diseases

  2008cites this paper
• "NeuroStem Chip": a novel highly specialized tool to study neural differentiation pathways in human stem cells

  2007cites this paper
• Amniotic fluid derived stem cells ameliorate focal cerebral ischaemia-reperfusion injury induced behavioural deficits in mice.

  2007cites this paper
• A critical analysis of evidence for using sham surgery in Parkinson's disease: implications for public health

  2007cites this paper
• Neural transplantation in Parkinson's Disease

  2007cites this paper
• Nucleofection Is the Most Efficient Nonviral Transfection Method for Neuronal Stem Cells Derived from Ventral Mesencephali with No Changes in Cell Composition or Dopaminergic Fate

  2006cites this paper
• Long-term assessment of striatal dopamine transporters in parkinsonian patients with intrastriatal embryonic mesencephalic grafts

  2006cites this paper
• Evidence-Based Methodology for Advancing Neural Reconstruction

  2006influential citation
• Restorative Therapies for Parkinson's Disease: Ethical Issues

  2006cites this paper
• Locomotor Training in People With Parkinson Disease

  2006cites this paper
• Between truth and hope: on Parkinson’s disease, neurotransplantation and the production of the ‘self’

  2005cites this paper
• Can stem cells cure Parkinson's disease? Embryonic steps toward a regenerative brain medicine

  2005cites this paper
• Ethics, methodology and the use of placebo controls in surgical trials.

  2005cites this paper
• Factors affecting the clinical outcome after neural transplantation in Parkinson's disease.

  2005cites this paper
• Stem cell‐based therapy for Parkinson's disease

  2005cites this paper
• Cell therapy for neurological disorders: a comprehensive review.

  2005cites this paper
• Stem cell therapy for human brain disorders.

  2005cites this paper
• Adult neural stem cell therapy: expansion in vitro, tracking in vivo and clinical transplantation.

  2005cites this paper
• Cell-based therapies for disorders of the CNS

  2005cites this paper
• Functional properties and synaptic integration of genetically labelled dopaminergic neurons in intrastriatal grafts

  2005cites this paper
• The design of clinical trials for cell transplantation into the central nervous system

  2004cites this paper
• Recovery and Rehabilitation in Stroke: Stem Cells

  2004cites this paper
• Bone marrow grafts restore cerebral blood flow and blood brain barrier in stroke rats.

  2004cites this paper
• Stem cell therapy for human neurodegenerative disorders–how to make it work

  2004cites this paper
• ASSESSMENT OF PHARMACOKINETIC INTERACTION OF L-DOPA AND BENSERAZIDE

  2004cites this paper
• Intracerebral xenografts of mouse bone marrow cells in adult rats facilitate restoration of cerebral blood flow and blood-brain barrier.

  2004cites this paper
• Olle Lindvall and Zaal Kokaia Recovery and Rehabilitation in Stroke : Stem Cells

  2004cites this paper
• How Can Stem Cell Therapy Be Developed for Stroke Patients ?

  2004cites this paper
• The Future of Cell-Based Transplantation Therapies for Neurodegenerative Disorders

  2003cites this paper